Clinical Trial Update: Individualized Antithrombotic Therapy for Patients With Ischemic Cerebrovascular Disease [Phase 1]

View source ↗

Summary

This entry reports an early-stage clinical trial evaluating individualized antithrombotic therapy for ischemic cerebrovascular disease (Phase 1). The study stat…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ischemic Cerebrovascular Disease

Snippet

Sponsor: Xuanwu Hospital, Beijing | Conditions: Cerebrovascular Disease | Phase 1 | Status: UNKNOWN